Cost of Cancer Treatments – Natural Allopathic Vs. Allopathic

The Natural Allopathic Medicine protocol that I have developed is effective for most diseases. The first 4-7 components of the 17 level protocol gives lower-income or under-insured people of the world a fighting chance of recovering from cancer or other diseases. The core of the protocol are natural emergency room and intensive care medicines with extraordinary medical horsepower. They include magnesium salts, sodium bicarbonate, iodine, selenium, glutathione and vitamin C.

Cost of the most basic seven them could be as low as $250 a month or roughly $7.50 a day. Add low-cost walks in the sun, purified water and homegrown medical marijuana and one has a protocol that powerful and safe. Treatments with concentrated nutritional medicines far surpass toxic oncology treatments with respect to a positive outcome without the risk of negative side effects that oncologists fear when they themselves fall victim to cancer.

To incorporate the full protocol we can estimate that it would cost approximately $7,000 for a six month treatment plan, which is necessary for late-stage cancers, though cancer can sometimes be cured in less time for less cost if a person has not been damaged by radiation, surgery and/or chemotherapy.

This would include all the medicinals (supplements selected from the best companies offering the best products) sustained at high dosage levels, full professional support through phone and text chat/ email, and an array of medical equipment that the whole family can use for years to come.

Included at this cost level are some very interesting pieces of medical equipment/ healing devices that facilitate quicker and easier returns to health. The full protocol gives each individual and their family full control over their medical destiny.

Included is a far-infrared BioMat, EarthPulse, and a breathing retraining device (an important treatment component ignored by just about everyone). Breathing device is Russian medical technology coming to the west offering levels of treatment until now available in the west.

This cost would not include massages (that can be done by a family member at home), home nursing support (that can also be provided by family), or other professional services or treatments.

Costs of Othodox Oncology

Researchers from Harvard University, National Cancer Institute, and National Bureau of Economic Research published in the December 1, 2007 issue of Cancer findings that the average life-expectancy for lung cancer patients raised by less than one month between 1983 and 1997, while costs rose by over $20,000 per patient. Cost effectiveness, as measured by the cost of an additional year of life gained, was poor, with a high average cost of $403,142. When analyzed by disease severity, the cost per additional year gained for local and regional disease was $143,614 and $145,861, respectively. For metastatic cancer, the cost per additional year gained was $1,190,322.

There’s a dramatic increase in the cost of the new drugs. And there’s
a shift by doctors to newer drugs that are substantially more expensive.
Dr. Len Lichtenfeld
                                                                  Editor for the American Cancer Society

Even patients with insurance are thinking hard before agreeing to treatment because out-of-pocket copayments for drugs that could easily run $10,000 to $20,000 a year. One of the few cancer drugs with a higher monthly price tag than usual is Erbitux. The drug, used for colon cancer, sells for $9,600 monthly. But don’t tell anyone that a late-stage clinical trial in advanced stomach tumors failed to show that Erbitux had any significant benefit in progression-free survival. It is the second blow for Erbitux in 2012.

Back in May Merck said there was no additional benefit when [Erbitux was] given with chemotherapy to colon cancer patients after surgery to remove their tumor. In December of 2012 the company got bad news about its innovative new lung cancer drug Stimuvax, which did not improve the overall survival of patients at all in its phase III study. Also in December a major trial of Merck & Co. Inc.’s Tredaptive medicine to increase “good” HDL cholesterol has raised safety concerns and showed it was no better at preventing heart attacks, deaths or strokes than traditional statin drugs that lower “bad” LDL cholesterol, the company said.

In modern oncology the cost of doing nothing is actually quite expensive. Active surveillance is a reasonable option for men with slow-growing cancers because it is not known whether treating the cancer with surgery or radiation will actually help them live longer. These treatments have definite risks and side effects that may outweigh the possible benefits for some men. Costs still range from $6558 to $11,992 a year if one is under the care of an oncologist.

Dr. Leslie S. Wilson, at the School of Medicine, University of California, compared costs of all prostate-related treatments over five-and-a-half years of 4,553 newly diagnosed men stratified by age, risk, and ethnicity. In the first six months, the mean cost after treatment was $11,495 and was directly impacted by treatment type. Cost ranged from only $2,568 for watchful waiting (by 2010 that cost was estimated to be $6,558 to $11,992) to $24,204 for external beam radiation. Subsequent annual cost was found to average $7,740 and ranged from $5,843 for watchful waiting to $12,590 for androgen deprivation therapy. Cumulative mean cost over 5.5 years for all risk groups was $42,570, with watchful waiting costing the least at $32,135 and androgen deprivation therapy costing the most at $69,244.

Fidelity Investments, which oversees some 12 million 401(k) accounts, has a study saying that an average 65-year-old couple retiring in 2012 would need to have $240,000 in savings to pay for out-of-pocket health-care costs in retirement. And that’s $240,000 in today’s dollars, so a couple retiring in 10 years would need the inflated-adjusted equivalent in the year 2022. (In its 11 years of doing this study, Fidelity has found the rate of health-care inflation to average 6% per year; assuming that rate stayed constant, a 2022 retiree would need about $430,000 set aside.) With 50 million people on food stamps I wonder how many Americans are going to have this kind of money. The cost of choosing the wrong medicine is not only expensive but it can also cost a person their life.

Forbes Magazine writes, “When people talk about expensive drugs, they usually are referring to drugs like Lipitor for high cholesterol ($1,500 a year), Zyprexa for schizophrenia ($7,000 a year) or Avastin for cancer ($50,000 a year). But none of these medicines come close to making Forbes’ exclusive survey of the most expensive medicines on the planet. The nine drugs on our list all cost more than $200,000 a year for the average patient who takes them. Alexion Pharmaceutical’s Soliris, at $409,500 a year, is the world’s single most expensive drug. Unlike pills that come in standard doses, all the most expensive drugs are injected biotech drugs whose dosing varies by weight or other factors.”